Figure 1.
Changes in plasma VEGF (A), placental growth factor (B), soluble VEGFR1 (C), and endoglin (D) concentrations from baseline to Day 28 of cycle 1 of sunitinib in 12 patients.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.